SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is generating intense community buzz as the stock holds steady near the $5 level amid heavy short interest and anticipation surrounding upcoming data updates at the AACR conference. Long-term shareholders remain focused on the potential for clinical trial readouts to trigger a significant revaluation, while actively debating the impact of upcoming options expiration and the feasibility of an early trial halt based on therapeutic efficacy.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio Inc. (IBRX) is currently experiencing high volatility driven by a combination of speculative options activity and market-maker pressure, leading the community to intensely debate the legitimacy of ongoing legal noise versus the company's strong long-term clinical potential. While some investors are frustrated by persistent price suppression and technical pullbacks, the active community remains bullish, citing a powerful 'gamma squeeze' setup, imminent international commercial launches, and the potential for a breakout fueled by institutional accumulation.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as the stock surges following regulatory approval from Greenland to increase its stake in the Tanbreez rare earth project to over 90%. Investors are actively discussing the potential for a massive short squeeze and long-term revaluation, with many citing the strategic importance of the asset for Western supply chain independence and potential interest from institutional or government buyers.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Mining Inc

Cipher Mining is generating significant buzz as investors weigh its robust hyperscaler contract pipeline against recent sector-wide volatility and geopolitical headwinds. The community is actively debating the company's valuation gap compared to its peers, with many seeing the current price action as a potential accumulation zone while others express frustration over institutional selling patterns.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion Inc. (INFQ) is surging on massive volume as investors pivot to the company following its strategic inclusion in NVIDIA's quantum ecosystem, positioning it as a significant partner for AI-integrated quantum hardware. Community sentiment is overwhelmingly bullish, with traders viewing the stock as an undervalued leader in neutral-atom technology and highlighting its strong pipeline of government and commercial contracts compared to sector peers.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors digest a series of positive clinical trial developments alongside optimism regarding upcoming institutional data and regulatory milestones. The community remains deeply divided, with long-term believers citing the company's platform potential and pipeline depth, while skeptical traders point to extended timelines and historical price volatility as key concerns.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group is experiencing intense market volatility driven by aggressive short squeeze dynamics and speculative retail interest, with social sentiment divided between those chasing the parabolic momentum and traders anticipating a sharp correction. The discussion is dominated by concerns over potential institutional manipulation, the lack of fundamental justification for the rapid price appreciation, and widespread debates regarding the timing of an inevitable reversal.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is experiencing high-volatility price action and massive call option volume as investors position for potential regulatory approvals and a major data center power partnership. Community sentiment remains deeply divided between long-term bulls betting on the company's AI-linked energy infrastructure and vocal critics focused on the lack of current revenue, pending litigation, and speculative leadership.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp is trending as investors rally behind a potential short squeeze, fueled by the SEC's recent removal of the restrictive Pattern Day Trader rule and the company's termination of a dilutive equity agreement. The community is actively debating the stock's massive upside potential, with many accumulating shares on dips in anticipation of a sustained run toward higher resistance levels.

AABG Token

AABB is currently trending as shareholders analyze the company's latest corporate updates, including progress on its modular gold recovery plant and the upcoming release of its GoldAxis wallet and silver-backed tokens. The community is actively debating the company's long-term execution and transparency against concerns from short-sellers, while many investors highlight their continued accumulation of shares as a strategy to build position ahead of anticipated milestones.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Joe Palmer

Savetheworld4

Jonny Doom And Gloom

Rudy Duvnjak

pedmac

$INKT $AGEN $IBRX  
The next wave in cancer treatment won’t be another Keytruda clone. 
 
It will be therapies that work where Keytruda fails — in cold, refractory tumors. 
 
MiNK Therapeutics + Agenus + ImmunityBio 
This is immune system reprogramming, not just checkpoint blocking. 
 
That’s where the real disruption begins with groundbreaking treatments.